-

US Vaccine Trickle Must be a Flood to End COVID-19, says AHF

LOS ANGELES--(BUSINESS WIRE)--The White House announced today that the US has shipped 400 million doses of COVID-19 vaccines around the world, a milestone that AIDS Healthcare Foundation (AHF) described as commendable but still far short of what is needed to vaccinate our world.

“Over 3.5 billion people around the world are not yet fully vaccinated, which means nearly 50% of the global population is unprotected from COVID-19 and susceptible to developing new variants of the virus. Shipping 400 million doses is great, but not enough – we need billions more to slow down the pandemic,” said Tom Myers, AHF Chief of Public Affairs and General Counsel. “The US can and should do more, but it doesn’t have to shoulder all of the weight – pharma companies must be compelled to share their technologies and patents so that production can be expanded in other countries.”

The US has either purchased or has options on a total of 2.6 billion vaccine doses, far in excess of what is needed to fully vaccinate its population of nearly 330 million people. That means a surplus of well over 1 billion doses can be dispatched to other hard-hit regions, such as Africa, where less than 16% of people have received even one vaccine dose. The EU has the second-largest stockpile of vaccines with around 2 billion doses.

There is enough global capacity to fully meet the demand for vaccines. Until the world is awash in billions of readily available doses, modest donations of a few hundred million doses will remain a drop in a bucket.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million clients in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

AIDS Healthcare Foundation (AHF)


Release Versions

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

More News From AIDS Healthcare Foundation (AHF)

AHF: Florida Lawmakers Reverse HIV Drug Cuts, Restoring Coverage for Thousands

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Thousands of Floridians living with HIV will keep the medication that keeps them alive, after the Florida Legislature today passed a state budget that reverses this year's cuts to the AIDS Drug Assistance Program (ADAP). The budget returns eligibility to 400 percent of the federal poverty level, brings back the medications the Department of Health had dropped, including Biktarvy, funds the program with $75 million, and adds independent oversight. "This is wha...

AHF Calls for Access and Dignity on Menstrual Health Day

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) joins the global commemoration of Menstrual Health Day with events across nearly 50 countries, highlighting the importance of reducing period stigma and expanding access to affordable menstrual products—critical steps in protecting overall health and reducing vulnerability to HIV and other sexually transmitted infections. Menstrual Health Day is observed annually on May 28. Around the world, barriers to menstrual health continue to...

Ebola Crisis Exposes Failure of Current Global Health Architecture, says AHF

LOS ANGELES--(BUSINESS WIRE)--As Uganda and the Democratic Republic of the Congo (DRC) confront a rapidly evolving Ebola outbreak, AIDS Healthcare Foundation (AHF) warns that the crisis highlights persistent weaknesses in the world’s ability to respond quickly and equitably to emerging infectious disease threats. The current outbreak involves the Bundibugyo strain of Ebola virus, for which no approved vaccines or therapeutics currently exist, heightening concerns among global health officials a...
Back to Newsroom